Cell Well Liquid
NDC Package 85946-0001-1
Package Information
Cell Well (calcium carbonica, calcium fluoratum, calcium phosphoricum, calcium sulphuricum, ferrum phosphoricum, kalium muriaticum, kalium phosphoricum, kalium sulphuricum, magnesium carbonica, magnesium phosphoricum, natrum muriaticum, natrum phosphoricum, natrum sulphuricum, silicea) liquids is adults take 1 dropper sublingually 2-4 times daily. This formulation utilizes a liquid delivery system. Marketed by Joywell Co Llc, this product is identified by NDC 85946-0001.
Identification & Billing
Clinical Specifications
- CALCIUM FLUORIDE 6 [hp_X]/60mL
- CALCIUM PHOSPHATE, UNSPECIFIED FORM 6 [hp_X]/60mL
- CALCIUM SULFATE, UNSPECIFIED FORM 6 [hp_X]/60mL
- FERROSOFERRIC PHOSPHATE 6 [hp_X]/60mL
- MAGNESIUM CARBONATE 6 [hp_X]/60mL
- MAGNESIUM PHOSPHATE ANHYDROUS 6 [hp_X]/60mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/60mL
- POTASSIUM CHLORIDE 6 [hp_X]/60mL
- POTASSIUM PHOSPHATE, UNSPECIFIED FORM 6 [hp_X]/60mL
- POTASSIUM SULFATE 6 [hp_X]/60mL
- SILICON DIOXIDE 6 [hp_Q]/60mL
- SODIUM CHLORIDE 6 [hp_X]/60mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 6 [hp_Q]/60mL
- SODIUM SULFATE 6 [hp_X]/60mL
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Blood Coagulation Factor - [EPC] (Established Pharmacologic Class)
- Calcium - [CS]
- Cations, Divalent - [CS]
- Increased Coagulation Factor Activity - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Phosphate Binder - [EPC] (Established Pharmacologic Class)
- Phosphate Chelating Activity - [MoA] (Mechanism of Action)
- Potassium Compounds - [CS]
- Potassium Salt - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 85946 - Joywell Co Llc
- 85946-0001 - Cell Well
- 85946-0001-1 - 60 mL in 1 BOTTLE, DROPPER
- 85946-0001 - Cell Well
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 85946-0001-1 identifies a specific commercial package of 60 ml in 1 bottle, dropper of Cell Well, a human over the counter drug labeled by Joywell Co Llc. This liquid is formulated for oral use and contains calcium fluoride; calcium phosphate, unspecified form; calcium sulfate, unspecified form; ferrosoferric phosphate; magnesium carbonate; magnesium phosphate anhydrous; oyster shell calcium carbonate, crude; potassium chloride; potassium phosphate, unspecified form; potassium sulfate; silicon dioxide; sodium chloride; sodium phosphate, dibasic, heptahydrate; sodium sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Joywell Co Llc on November 19, 2025. The current certification is valid through December 31, 2026.
How is this Joywell Co Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 85946000101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.